Yuksekkaya R, Celikyay F, Yuksekkaya M, Kutluturk F. Shear wave elastography in early diabetic kidney disease.
Rev Assoc Med Bras (1992) 2022;
68:765-769. [PMID:
35584435 PMCID:
PMC9575911 DOI:
10.1590/1806-9282.20211042]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 02/10/2022] [Indexed: 11/22/2022] Open
Abstract
OBJECTIVE:
This study aimed to analyze the kidneys among the subjects with early stages
of type 2 diabetic kidney disease by shear wave elastography
quantitatively.
METHODS:
A total of 108 patients with type 2 diabetic kidney disease and 17 control
subjects were enrolled. According to the estimated glomerular filtration
rate and urinary albumin-to-urinary creatinine ratio, patients were
classified into stages 1 to 3 diabetic kidney disease. Grayscale ultrasound
andshear wave elastography were performed. The sizes, depths, and shear wave
elastography values were recorded. These parameters were compared between
the diabetic kidney disease and the control subjects.
RESULTS:
The mean shear wave elastography values were significantly higher in the
diabetic kidney disease group (10.156±1.75 kPa vs. 8.241±1.4 kPa;
p<0.001). We obtained statistically significantly higher shear wave
elastography values in stages 2 and 3 diabetic kidney disease subjects than
control subjects and in patients with stage 3 diabetic kidney disease
compared to those with stage 1 diabetic kidney disease (p<0.05 for all).
We obtained a cutoff value of 9.23 kPa for predicting diabetic kidney
disease in early stages, with a sensitivity of 67% and a specificity of
82%.
CONCLUSION:
Shear wave elastography may be used as a noninvasive, simple, and
quantitative method to provide diagnostic information as a part of routine
management of patients with type 2 diabetes mellitus, especially in the
early stages of diabetic kidney disease.
Collapse